ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/07/18 | 2,366 | 2,389 | 2,342 | 2,355 | -2 | -0.1% | 77,600 |
2018/07/17 | 2,318 | 2,358 | 2,303 | 2,357 | +39 | +1.7% | 92,200 |
2018/07/13 | 2,316 | 2,344 | 2,301 | 2,318 | +11 | +0.5% | 54,900 |
2018/07/12 | 2,304 | 2,345 | 2,304 | 2,307 | +4 | +0.2% | 84,700 |
2018/07/11 | 2,300 | 2,318 | 2,293 | 2,303 | -1 | ±0% | 103,500 |
2018/07/10 | 2,325 | 2,335 | 2,304 | 2,304 | -18 | -0.8% | 96,000 |
2018/07/09 | 2,316 | 2,330 | 2,302 | 2,322 | +7 | +0.3% | 51,900 |
2018/07/06 | 2,321 | 2,327 | 2,311 | 2,315 | -7 | -0.3% | 90,300 |
2018/07/05 | 2,343 | 2,356 | 2,318 | 2,322 | -25 | -1.1% | 56,400 |
2018/07/04 | 2,311 | 2,357 | 2,311 | 2,347 | +23 | +1% | 47,400 |
2018/07/03 | 2,315 | 2,332 | 2,306 | 2,324 | +9 | +0.4% | 70,300 |
2018/07/02 | 2,384 | 2,384 | 2,315 | 2,315 | -82 | -3.4% | 77,000 |
2018/06/29 | 2,387 | 2,402 | 2,359 | 2,397 | +9 | +0.4% | 52,200 |
2018/06/28 | 2,413 | 2,413 | 2,374 | 2,388 | -24 | -1% | 58,900 |
2018/06/27 | 2,351 | 2,419 | 2,351 | 2,412 | +66 | +2.8% | 88,100 |
2018/06/26 | 2,330 | 2,355 | 2,308 | 2,346 | +16 | +0.7% | 60,300 |
2018/06/25 | 2,349 | 2,354 | 2,320 | 2,330 | -15 | -0.6% | 89,200 |
2018/06/22 | 2,357 | 2,369 | 2,307 | 2,345 | -12 | -0.5% | 190,600 |
2018/06/21 | 2,355 | 2,384 | 2,327 | 2,357 | +2 | +0.1% | 112,500 |
2018/06/20 | 2,383 | 2,400 | 2,346 | 2,355 | -25 | -1.1% | 104,000 |
2018/06/19 | 2,409 | 2,430 | 2,375 | 2,380 | -8 | -0.3% | 121,400 |
2018/06/18 | 2,389 | 2,478 | 2,340 | 2,388 | +93 | +4.1% | 254,600 |
2018/06/15 | 2,284 | 2,321 | 2,278 | 2,295 | +15 | +0.7% | 100,300 |
2018/06/14 | 2,302 | 2,302 | 2,269 | 2,280 | -31 | -1.3% | 42,600 |
2018/06/13 | 2,285 | 2,329 | 2,285 | 2,311 | +33 | +1.4% | 45,800 |
2018/06/12 | 2,270 | 2,294 | 2,267 | 2,278 | +4 | +0.2% | 30,300 |
2018/06/11 | 2,269 | 2,282 | 2,240 | 2,274 | +12 | +0.5% | 43,900 |
2018/06/08 | 2,259 | 2,286 | 2,253 | 2,262 | -13 | -0.6% | 82,100 |
2018/06/07 | 2,320 | 2,320 | 2,268 | 2,275 | -33 | -1.4% | 51,900 |
2018/06/06 | 2,258 | 2,316 | 2,254 | 2,308 | ±0 | ±0% | 48,000 |
2018/06/05 | 2,282 | 2,310 | 2,274 | 2,308 | +17 | +0.7% | 33,800 |
2018/06/04 | 2,295 | 2,300 | 2,275 | 2,291 | +14 | +0.6% | 52,500 |
2018/06/01 | 2,242 | 2,289 | 2,234 | 2,277 | +33 | +1.5% | 56,900 |
2018/05/31 | 2,226 | 2,250 | 2,203 | 2,244 | +18 | +0.8% | 74,900 |
2018/05/30 | 2,251 | 2,255 | 2,225 | 2,226 | -56 | -2.5% | 42,500 |
2018/05/29 | 2,275 | 2,294 | 2,260 | 2,282 | +7 | +0.3% | 31,600 |
2018/05/28 | 2,322 | 2,322 | 2,263 | 2,275 | -36 | -1.6% | 44,100 |
2018/05/25 | 2,296 | 2,339 | 2,296 | 2,311 | -30 | -1.3% | 55,600 |
2018/05/24 | 2,293 | 2,355 | 2,293 | 2,341 | +56 | +2.5% | 73,400 |
2018/05/23 | 2,272 | 2,299 | 2,272 | 2,285 | +17 | +0.7% | 58,400 |
2018/05/22 | 2,294 | 2,304 | 2,265 | 2,268 | -48 | -2.1% | 71,400 |
2018/05/21 | 2,333 | 2,348 | 2,307 | 2,316 | -27 | -1.2% | 44,200 |
2018/05/18 | 2,369 | 2,373 | 2,340 | 2,343 | -26 | -1.1% | 55,600 |
2018/05/17 | 2,380 | 2,396 | 2,365 | 2,369 | -5 | -0.2% | 50,300 |
2018/05/16 | 2,348 | 2,387 | 2,340 | 2,374 | +25 | +1.1% | 90,100 |
2018/05/15 | 2,342 | 2,355 | 2,328 | 2,349 | +18 | +0.8% | 92,300 |
2018/05/14 | 2,271 | 2,347 | 2,258 | 2,331 | -17 | -0.7% | 120,600 |
2018/05/11 | 2,320 | 2,348 | 2,314 | 2,348 | +22 | +0.9% | 83,200 |
2018/05/10 | 2,285 | 2,341 | 2,279 | 2,326 | +57 | +2.5% | 92,500 |
2018/05/09 | 2,307 | 2,310 | 2,251 | 2,269 | -38 | -1.6% | 64,400 |
1551~
1600
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 226,400円 | +13.6% | +29.2% | 2.03% | 11.74倍 | 1.13倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 480,000円 | +12.0% | +28.1% | 2.50% | 26.46倍 | 1.12倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 333,500円 | +3.0% | +27.5% | 2.40% | 21.12倍 | 0.92倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 113,100円 | +197.7% | - | 0.00% | 46.22倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 150,000円 | +3.2% | +4.5% | 3.47% | 17.23倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム